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world population is affected by AR and that the prevalence of allergic diseases is drastically increasing in both
developing and developed countries. Ingestion of honey is widely believed to be a natural remedy to reduce
symptoms of allergic rhinitis. There are many theories addressing the mechanism(s) of action in which honey
may treat AR symptoms. Many of these theories are postulated as a result of research evidence garnered from
animal trials. This systematic review is to evaluate human studies looking at whether ingestion of honey can be
used as a complementary or alternative form of therapy in treating allergic rhinitis.
Methods: An exhaustive literature search was conducted to identify relevant published papers using Medline-
OVID, CINAHL, PubMed, and Web of Science using the keywords: honey and allergic rhinitis. Quality of
relevant articles was assessed using the GRADE criteria.
Results: Two randomized control trials met the inclusion criteria. One randomized, double blinded study
published in 2013 demonstrated a statistically significant reduction of symptoms in the local honey group
when compared to the control group. Another randomized, double blinded study published in 2002
demonstrated no therapeutic effect for either local honey or commercial honey in reducing symptoms of
allergic rhinitis when compared to the control group.
Conclusion: The results from each study were contradictory. Both studies had limitations in design and
methodology which reduced their quality of evidence. Overall quality of evidence is low. A weak
recommendation can be made in support of using oral ingestion of local honey as an adjunct in treating
symptoms of allergic rhinitis. There was no evidence of effect using commercial honey when compared to
placebo. Further research in the form of large population RCTs is needed to validate the results presented by
these studies.
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Abstract   
 
Background: Allergic rhinitis (AR) is a common disorder worldwide. Estimates show 
that 10% to 30% of the world population is affected by AR and that the prevalence of 
allergic diseases is drastically increasing in both developing and developed countries. 
Ingestion of honey is widely believed to be a natural remedy to reduce symptoms of 
allergic rhinitis. There are many theories addressing the mechanism(s) of action in which 
honey may treat AR symptoms. Many of these theories are postulated as a result of 
research evidence garnered from animal trials. This systematic review is to evaluate 
human studies looking at whether ingestion of honey can be used as a complementary or 
alternative form of therapy in treating allergic rhinitis. 
 
Methods:  An exhaustive literature search was conducted to identify relevant published 
papers using Medline-OVID, CINAHL, PubMed, and Web of Science using the 
keywords: honey and allergic rhinitis. Quality of relevant articles was assessed using the 
GRADE criteria. 
 
Results:  Two randomized control trials met the inclusion criteria. One randomized, 
double blinded study published in 2013 demonstrated a statistically significant reduction 
of symptoms in the local honey group when compared to the control group. Another 
randomized, double blinded study published in 2002 demonstrated no therapeutic effect 
for either local honey or commercial honey in reducing symptoms of allergic rhinitis 
when compared to the control group. 
 
Conclusion:  The results from each study were contradictory. Both studies had 
limitations in design and methodology which reduced their quality of evidence. Overall 
quality of evidence is low. A weak recommendation can be made in support of using oral 
ingestion of local honey as an adjunct in treating symptoms of allergic rhinitis. There was 
no evidence of effect using commercial honey when compared to placebo. Further 
research in the form of large population RCTs is needed to validate the results presented 
by these studies.   
 
Keywords:  honey, seasonal allergic rhinitis, perennial allergic rhinitis, allergic rhinitis 
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Local, Unpasteurized Honey as a Treatment for Allergic Rhinitis: A Systematic Review 
BACKGROUND 
Allergic rhinitis (AR) is a common disorder worldwide. Estimates show that 10% 
to 30% of the world population is affected by AR and that the prevalence of allergic 
diseases is drastically increasing in both developing and developed countries.1 The 
medical costs associated with AR are approximated at 6 billion annually in the United 
States alone.2 A predisposed individual suffers from symptoms of AR when they are 
exposed to an allergen. Allergic rhinitis is a seasonal or perennial inflammatory disease 
that is classically characterized by inflammation of the nasal passages, rhinorrhea, nasal 
congestion and sneezing. Ocular symptoms are commonly seen as well.3  
Those afflicted with AR have an assortment of current medical therapies and 
recommendations available for use which include intranasal corticosteroids, 
antihistamines, and allergen avoidance. Other adjunctive medical therapies and measures 
include:  decongestants, cromolyn sodium, leukotriene modifiers, intranasal 
anticholinergic agents, and allergy immunotherapy. Many of these are sometimes 
ineffective or expensive and have various side effects.4-8 Allergy immunotherapy by 
subcutaneous injection or sublingual route is more effective than placebo in treating 
patients who fail other medical therapies and has been shown to relieve symptoms of AR 
in up to 80% of patients. Current recommendations for immunotherapy are for those with 
severe AR which is refractory to medication.9-11 A commonly considered drawback to 
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injection immunotherapy is the need to travel to a shot clinic on a regular basis to receive 
injections.12 Additionally, immunotherapy has a high initial cost associated with it. 
However, research indicates that there may be significant cost savings recognized after 3 
months of immunotherapy treatment for patients <18 years of age.13 
As an alternative to medical therapy, ingestion of honey is widely believed to be a 
natural remedy to reduce symptoms of allergic rhinitis. There are many theories 
addressing the mechanism(s) of action in which honey may treat AR symptoms. Many of 
these theories are postulated as a result of research evidence garnered from animal trials. 
For instance, one component of honey, honeybee-collected pollen, has been shown to 
inhibit IgE-mediated mast cell activation from both in vivo and in vitro studies 
demonstrating a possible anti-allergic mechanism.14,15 Another study16 in mice 
demonstrated that ovalbumin-specific IgE responses elicited with a range of doses were 
completely suppressed by using different sources of commercially available honey. There 
is extensive evidence in human and animal studies which demonstrate that honey 
possesses anti-inflammatory properties.17-21 
Perhaps the most widely believed theory is that ingestion of locally collected, 
unpasteurized honey works similar to immunotherapy. Bees play an important role by 
collecting pollen from flowering plants. In addition to floral pollen, bees collect 
windborne pollen during flight. It has been postulated that with sufficient pollen 
concentrations present in honey an oral low-dose tolerance to specific aeroallergens may 
be developed in a similar mechanism to sublingual immunotherapy.22 
Few studies exist which evaluate whether honey has a therapeutic effect on 
symptoms of allergic rhinitis. This systematic review is to evaluate those studies and 
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grade the level of evidence to make recommendations on whether ingestion of local, 
unpasteurized honey can be used as a complementary or alternative form of therapy in 
treating allergic rhinitis. 
METHODS 
An exhaustive literature search was conducted to identify relevant published 
articles using Medline-OVID, CINAHL, PubMed, and Web of Science using the 
keywords: honey and allergic rhinitis. Bibliographies from the discovered articles were 
cross-referenced for additional relevant sources.  Inclusion criteria consisted of studies 
done on humans and studies published in the English language. Studies were excluded if 
researchers failed to perform allergen scratch testing on participants at study onset or if 
the honey was taken by any route other than orally. Quality of relevant articles was 
assessed using the Grading of Recommendations, Assessment, Development and 
Evaluation (GRADE) criteria.23 A search of The National Institute of Health clinical 
trials website revealed no currently registered trials regarding the use of oral ingestion of 
honey in association with treatment for allergic rhinitis 
RESULTS 
The initial search yielded a total of 54 articles for review. After removing 
duplicate articles there were two remaining studies which met the inclusion and exclusion 
criteria. Both studies are randomized control trials.22,24  See Table I. 
Asha’ari et al study 
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 This randomized, double-blinded, placebo-controlled trial24 was conducted over a 
1 year period from April 2010-April 2011. Participants in the study were recruited from 
an otolaryngology clinic in two tertiary referral centers located along the East coast of 
Peninsular Malaysia. The sample size was determined using power analysis software to 
an 80% power of study. Symptom history was gathered and subjects were tested by skin 
prick for common allergens in the area. Subjects whose skin prick test was negative were 
excluded from the study. Each subject was then graded using the Allergic Rhinitis and its 
Impact on Asthma (ARIA) classification.24,25 
Forty participants between the ages of 20-50 years were divided into two equally-
sized, prognostically balanced groups. All participants took 10 mg Loratadine (second-
generation antihistamine) once daily for the first 4 weeks of the study, after which all 
participants discontinued use of the antihistamine. The case group received Tualong 
honey, a raw, unprocessed, and multifloral honey harvested from the Malaysian 
rainforest. The control group received honey-flavored corn syrup. All subjects were 
instructed to consume 1 gram per kilogram of body weight each day in separate doses for 
the first 4 weeks of the study period. In addition to this, all subjects were instructed to not 
consume any other products which included honey during the study period.  Subjects 
were given a diary to fill out daily to record dosage taken and any possible side effects. 
Subjects were then instructed to mail each diary to the researchers on a weekly basis for 
the first 4 weeks of the study. The researchers make no mention regarding loss to follow-
up.24 
Seven symptoms were assessed to determine treatment effect (Table II). Symptom 
scores for each participant were recorded at study onset, week 4(day 28), and week 8(day 
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56). For the scoring, the participant evaluated the severity of individual symptoms using a 
7-point visual analog scale which was published by The Joint Task Force on Practice 
Parameters on Allergy, Asthma, and Immunology.24,26 Researchers regarded AR 
symptoms as present when a score of at least three was reported by the participant.24 
On data analysis the researchers calculated the mean and the standard deviation 
for the total symptom score of the control and the case groups at the start of the study, at 
week 4, and again at week 8. Comparisons were completed using ANOVA and t test 
analysis techniques. Initial findings demonstrated no significant differences observed 
between the case and control group at study onset, week 4, and week 8. Post hoc 
comparisons were made between the weeks in the case group and control group using 
paired samples t tests. Statistically significant differences were observed within the case 
group between the mean total symptom scores of week 0 and week 4 (mean difference 
3.05 (± 4.76) P=0.010), week 4 and week 8 (mean difference 2.30 (±3.28) P=0.005), and 
week 0 and week 8 (mean difference 5.35 (±4.98) P=0.000). In the control group, 
statistically significant differences were observed between the mean total symptom scores 
of week 0 and week 4 (mean difference 2.10 (±4.15) P=0.036) and week 0 and week 8 
(mean difference 3.13 (±4.10) P=0.003), but not between week 4 and week 8 (mean 
difference 1.03 (±3.54) P=0.209). Based on the results of the study, the researchers 
determined that large doses of honey appear to improve the symptoms associated with 
AR over a short period and that there is indication that local honey could serve as an 
adjunct therapy for AR.24 See Table III. 
The researchers stated that the results of the study need to be considered 
preliminary as they identified various limitations of the study. The first limitation they 
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identified was that symptom scoring was determined using clinical criteria. They 
attempted to minimize this bias by using a validated scoring instrument and by having the 
same independent assessor conduct the symptom score for each patient throughout the 
study. Another limitation the researchers addressed is that the honey used in the study is a 
raw, unprocessed local honey and the results are only relevant to the lot of honey 
consumed in the study. Lastly, the researchers acknowledged a relatively small sample 
size for the study and stated that evidence from a larger randomized-control trial is 
needed to provide validation to the results of the study.24 
Rajan et al study 
 This randomized, double-blinded, placebo-controlled trial22 was conducted at the 
University of Connecticut Health Center’s Lowell P. Weicker General Clinical Research 
Center. Using a power analysis, the authors determined that at least 9 participants per 
group, 27 total, were needed for the study.  Symptom history was gathered and 
participants were scratch tested for common seasonal allergens in the region upon entry 
into the study. Scratch test results were recorded and the patients’ forearms were 
photographed; this data was stored for future blinded evaluation.22 
Thirty-six participants between the ages of 20-70 years who complained of 
symptoms of allergic rhinoconjunctivitis were recruited and divided into three different 
cohorts. The first group (11 females, 2 males) received corn syrup with synthetic honey 
flavoring as a control. The second group (6 females, 5 males) received locally collected, 
unpasteurized and unfiltered honey. The third group (7 females, 5 males) received 
nationally collected, pasteurized and filtered honey. Participants were to consume one 
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tablespoon per day for 30 weeks and to record daily, in a diary provided, both nasal and 
ocular symptoms (Table IV) using a scale of 0 to 3, in addition to use of any allergy 
medication. Participants mailed their records to the researchers on a weekly basis. 
Twenty-three participants completed the study after loss to follow-up:  seven participants 
remained in the placebo group, nine in the local honey group, and seven in the nationally 
collected honey group.22  
On data analysis, the researchers divided the allergy season into 4 periods 
representing the common local aeroallergens.  The researchers stated that it would be 
most clinically useful if subjects experienced no allergy symptoms, so they only 
evaluated each group by days with symptoms or days with no symptoms in a 
dichotomous format. The researchers combined the 10 subjective symptoms with the 
number of days participants used allergy medication and measured them across all four 
seasonal periods to result in 44 parameters. They found that the placebo group 
outperformed the other two groups in 19 of the 44 parameters, the local honey 
outperformed the other two groups in 18 of the 44 parameters and the national honey 
outperformed the other two groups in 7 of the 44 parameters. They noted there was no 
consistent improvement in symptoms for any group.22 
Upon review of the scratch test results after completion of the study, the 
researchers found that only 14 of the 23 remaining participants demonstrated scratch test 
reactivity to the seasonal allergens which were tested. Of these 14 participants, 3 
remained in the placebo group, 6 in the local honey group, and 5 in the national honey 
group. The researchers determined which participants were benefited by the treatment 
regimen based on their positive scratch test results correlated to their symptom reporting 
 - 14 -  
during the relevant seasons. It was determined by the researchers that 2 of 3 participants 
in the placebo group, 2 of 6 participants in the local honey group, and 3 of 5 participants 
in the national honey group were benefitted by treatment (Table V). The authors state that 
the 7 patients who benefitted by treatment were comparably divided among the three 
groups (P=0.65).  Based on the results the researchers determined that the study did not 
support the belief that honey is effective at reducing the symptoms of 
rhinoconjunctivitis.22 
The researchers reported that there were several possible limitations to the study. 
The first being that the dose of honey used could be inadequate to be effective. Another 
was the possibility that a longer treatment regimen might be required to reach adequate 
effect. They finally stated that the small size of the cohort would require that additional 
studies, using larger groups need to be conducted in order to confirm their findings.22 
DISCUSSION 
Allergic rhinitis affects individuals from all age ranges around the world, and 
studies indicate an increasing prevalence of AR worldwide.1 The annual medical costs 
associated with AR in the United States alone approach 6 billion.2 There is a widely held 
belief that honey can be effective in managing symptoms of AR. The mechanisms 
postulated by which honey may reduce symptoms of AR include: anti-inflammatory 
properties, a possible immunosuppressive effect, and immunotherapy in the form of low-
dose oral tolerance. Two randomized, double-blinded, placebo-controlled trials22,24 were 
evaluated in this systematic review to determine if honey may play a role in the treatment 
of AR, and their results were contradictory. The researchers from the article by Asha’ari 
et al24 determined that large doses of honey appear to improve the symptoms associated 
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with AR over a short period and that the results indicate it could serve as an adjunct 
therapy for AR. In the article by Rajan et al22 the researchers stated that their study did 
not support the belief that honey is effective at reducing the symptoms of 
rhinoconjunctivitis. These studies varied from each other by design, methodology, 
environment, and study population. In light of the contradicting results from the 
respective studies, significant consideration was given regarding the quality of both 
studies (Table I). Specifically, the Asha’ari et al study24 carries more validity than the 
Rajan et al study22 in regards to limitations and consistency; therefore, their results should 
be favored. Additionally, when considering the low risk of side effects associated with 
honey and the ease of availability, it was determined that local honey may be a safe, 
effective adjunct therapy to reduce symptoms of allergic rhinitis. However, larger RCTs 
are needed to validate this conclusion and to provide further insight into the mechanisms 
by which honey affects the human body. 
Limitations 
Both study22,24 outcomes of interest were underpowered due to small population 
size. The study by Rajan et al22 used a power analysis and determined that at least 9 
participants per group (minimum of 27 participants) were needed for the duration of the 
study to indicate statistical significance. There were 36 participants at study onset and, 
after loss to follow-up, only 23 participants remained at study completion. Additionally, 
it appeared that the results from the allergen scratch testing performed upon entry into the 
study were not reviewed until study completion. After review, the authors determined 
that only 14 participants remained who demonstrated a positive reaction to the scratch 
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test. In contrast, the study by Asha’ari et al24 excluded subjects who had a negative 
scratch test before entry into the study. This verified that all study participants were 
afflicted with AR. In the study by Asha’ari et al24 the researchers calculated sample size 
using power analysis as well. Forty patients were recruited and study results ranged over 
an 8 week period. However, the authors did not address loss to follow-up in their paper 
and so it is unknown how many participants completed the study, although there may 
have been no loss to follow up in this study as implied by the Degree of Freedom 
reported. In both articles the authors state that further trials using a larger cohort are 
needed to confirm their findings.  
A limitation of methodology that was present in both studies22,24 was that clinical 
criteria were used to evaluate symptoms. Ideally, patient-reported outcomes will be 
validated with some form of objective data. In the context of these studies an 
immunologic test may serve best. Both studies were limited by the inability to 
standardize raw, unpasteurized, local honey and therefore the results of the respective 
studies can only apply to the lot of local honey used in that study. It should be noted that 
the Rajan et al study22 also compared the use of pasteurized, filtered, commercially 
available honey.  
A limitation of methodology that is singular to the Rajan et al study22 is their 
choice of delineating that being symptom-free was the only clinically useful endpoint. Of 
interest to most clinicians is the symptom improvement at any level. This was measured 
in the Asha’ari et al study24; however, both studies22,24 failed to report the percent of 
patients who had a remarkable level of improvement of AR symptoms. 
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An inconsistency demonstrated in the Rajan et al study22 is that the three cohort 
groups were not prognostically balanced after randomization. The majority of the placebo 
group consisted of females (11 of 13), where females in the local honey group and the 
national honey group were more evenly balanced (6 of 11 and 7 of 12, respectively). 
Additionally, the only information concerning the patient characteristics upon entry to the 
study shared by the authors was the age ranges and the gender.  
In consideration of these limitations the quality of the study by Asha’ari et al24 has 
been downgraded to moderate and the quality of the study by Rajan et al22 has been 
downgraded to very low.  Further research is needed to validate the results presented by 
these studies.22,24 Recommendations for future studies would include conducting several 
large-population, double-blinded randomized control trials in different regions of the 
world. It would be beneficial if the studies were to compare local honey to the region and 
commercial honey with a control group. Allergen scratch testing to confirm presence of 
seasonal versus perennial allergies performed as a requirement for study participation 
would increase the range of treatment effect; patients with both seasonal and perennial 
allergies should be included and evaluated for any benefit. As stated previously, any 
objective way to validate patient-reported symptoms would add more predictive value to 
the study.  
CONCLUSION 
The results of the two studies22,24 evaluated in this systematic review were 
contradictory. The overall quality of evidence is low. A weak recommendation can be 
made in support of using local, unpasteurized honey as an adjunct in treating symptoms 
of allergic rhinitis. There was no evidence of effect using national, pasteurized honey 
 - 18 -  
when compared to placebo as assessed by the Rajan et al study.22 Further research in the 
form of large population RCTs is needed to validate the results presented by these 
studies.22,24 Additional studies formatted to provide further insight into the mechanisms 
by which ingested honey affects the human body would be beneficial as well. 
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Table I. Characteristics of Reviewed Studies 
 
 
a Small sample size 
b Researchers failed to account for patients who demonstrated symptom improvement who did not completely reach symptom-free status  
c Outcomes of interest are underpowered as a result of small final study population size. Authors stated they needed at least 9 participants per group (27 minimum) to have adequate determination of 
treatment effect, 13 patients dropped out of the study and scratch test results were unblinded after conclusion of study. Only 14 of the remaining participants demonstrated reactivity to seasonal 
allergen scratch testing. 
d Study groups and control group were not prognostically balanced 
 
Note: the local honey used in both studies is not standardized and therefore results from each study are only applicable to the batches of honey used during that trial 
Quality Assessment 
 Downgrade Criteria Quality 
Number of Participants Design Limitations Indirectness Imprecision Inconsistency Publication bias likely  
Ingestion of honey improves the symptoms of allergic rhinitis: evidence from a randomized placebo-controlled trial in the East Coast of Peninsular 
Malaysia (Asha'ari et al 2013) 
40 Double blinded RCT  No serious limitations
 No serious indirectness Serious imprecisiona No serious inconsistencies No bias likely Moderate 
Effect of ingestion of honey on symptoms of rhinoconjunctivitis (Rajan et al 2002) 
36 Double blinded RCT Serious limitations
b No serious indirectness Serious imprecisionc,d Serious inconsistenciesd No bias likely Very low 
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Table II. Symptoms tracked by Asha’ari et al study24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symptoms 
Hyposmia 
Rhinorrhea 
Nasal itchiness 
Eye itchiness 
Palatal itchiness 
Nasal blockage 
Sneezing 
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Table III. Results of Asha’ari et al study24 
 
 
 Local honey Placebo  Local Honey Placebo 
Week Mean total 
symptoms score 
Mean total 
symptoms score 
P value Mean (SD)  total symptoms 
score difference between weeks 
with P value 
Mean (SD) total symptoms 
score difference between weeks 
with P value 
Week 0 17.2 (3.64) 16.3 (4.45) 0.464   
Week 4 14.2 (4.85) 14.2 (4.87) 1.000   
Week 8 11.9 (5.66) 13.1 (4.28) 0.428   
Week 0-4    3.05 (4.76)        P=0.010 2.10 (4.15)        P=0.036 
Week 4-8    2.30 (3.28)        P=0.005 1.03 (3.54)        P=0.209 
Week 0-8    5.35 (4.98)        P=0.000 3.13 (4.10)        P=0.003 
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Table IV. Symptoms tracked by Rajan et al1 study22 
 
 
 
Ocular Symptoms Nasal symptoms 
Itchy eyes Itchy nose 
Watery eyes Runny nose 
Headache Sneezing 
Swollen eyes Stuffy/blocked nose 
Sore eyes Post-nasal drip 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table V. Results of Rajan et al study22 
 
 
 
 
 
 
 
 
 
*Participants who had positive scratch test results to seasonal allergens  
Group Benefitted by 
treatment 
regimen* 
Not benefitted by 
treatment 
regimen* 
Placebo 2 1 
Local honey 2 4 
National honey 3 2 
